When all breast cancers were analyzed as a group there was a shorter relapse-ree survival time for patients whose tumors contained low levels of CREB3L1 mRNA expression (hazard ratio (HR) = 1.27; p <0.0001) (Fig. 7a). The gene discussed is CREB3L1; the disease is breast carcinoma.